Financhill
Sell
47

DEI Quote, Financials, Valuation and Earnings

Last price:
$19.00
Seasonality move :
-1.29%
Day range:
$18.68 - $19.13
52-week range:
$12.36 - $20.50
Dividend yield:
4%
P/E ratio:
--
P/S ratio:
3.17x
P/B ratio:
1.52x
Volume:
805.2K
Avg. volume:
1.4M
1-year change:
24.77%
Market cap:
$3.2B
Revenue:
$1B
EPS (TTM):
-$0.10

Analysts' Opinion

  • Consensus Rating
    Douglas Emmett has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 9 Hold ratings, and 0 Sell ratings.
  • Price Target Downside
    According to analysts' consensus price target of --, Douglas Emmett has an estimated downside of -3.06% from its current price of $18.99.
  • Price Target Upside
    According to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $18.99.

Fair Value

  • According to the consensus of 11 analysts, Douglas Emmett has -3.06% downside to fair value with a price target of -- per share.

DEI vs. S&P 500

  • Over the past 5 trading days, Douglas Emmett has underperformed the S&P 500 by -0.03% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Douglas Emmett does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Douglas Emmett revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Douglas Emmett reported revenues of $250.8M.

Earnings Growth

  • Douglas Emmett earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Douglas Emmett reported earnings per share of $0.03.
Enterprise value:
9.7B
EV / Invested capital:
1.06x
Price / LTM sales:
3.17x
EV / EBIT:
52.83x
EV / Revenue:
9.71x
PEG ratio (5yr expected):
--
EV / Free cash flow:
42.98x
Price / Operating cash flow:
14.05x
Enterprise value / EBITDA:
16.32x
Gross Profit (TTM):
$648.9M
Return On Assets:
-0.17%
Net Income Margin (TTM):
-1.6%
Return On Equity:
-0.42%
Return On Invested Capital:
-0.17%
Operating Margin:
19.42%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $978.4M $1B $1B $255.4M $250.8M
Gross Profit $651.2M $658.5M $648.9M $163.5M $156M
Operating Income $234M $182.6M $189.6M $28.7M $48.7M
EBITDA $608.2M $627.8M $595.5M $157M $153.7M
Diluted EPS $0.52 $0.12 -$0.10 -$0.08 $0.03
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $344.9M $505.9M $722.9M $944.2M $785.2M
Total Assets $9.3B $9.4B $9.8B $9.8B $9.5B
Current Liabilities $271.6M $210.4M $209.1M $200.8M $194.4M
Total Liabilities $5.3B $5.4B $5.5B $5.8B $5.8B
Total Equity $4B $4B $4.3B $4B $3.7B
Total Debt $4.7B $5B $5.2B $5.5B $5.5B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations $489M $447.4M $429.3M $90.5M $103.7M
Cash From Investing -$553.3M -$244.3M -$209.8M -$60.4M -$46.3M
Cash From Financing -$5.2M $42.1M -$201.6M $233M -$74.3M
Free Cash Flow $259.8M $199.4M $226M $29.5M $56.4M
DEI
Sector
Market Cap
$3.2B
$1.1B
Price % of 52-Week High
92.63%
82.9%
Dividend Yield
4%
3.45%
Shareholder Yield
2.71%
3.4%
1-Year Price Total Return
24.77%
-4.55%
Beta (5-Year)
1.114
0.881
Dividend yield:
4%
Annualized payout:
$0.76
Payout ratio:
-791.62%
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $18.93
200-day SMA
Buy
Level $15.69
Bollinger Bands (100)
Buy
Level 16.02 - 19.12
Chaikin Money Flow
Buy
Level 216.7M
20-day SMA
Sell
Level $19.27
Relative Strength Index (RSI14)
Sell
Level 49.74
ADX Line
Buy
Level 18.83
Williams %R
Neutral
Level -55.5147
50-day SMA
Buy
Level $18.85
MACD (12, 26)
Sell
Level -0.04
25-day Aroon Oscillator
Sell
Level -12
On Balance Volume
Neutral
Level 165.9M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.3005)
Sell
CA Score (Annual)
Level (-1.5258)
Buy
Beneish M-Score (Annual)
Level (-2.7537)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-1.5394)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Douglas Emmett Inc is a real estate investment trust that acquires, develops, and manages office and multifamily properties in Los Angeles, California and Honolulu, Hawaii in the U.S. The company focuses on owning assets in communities with large supply constraints, such as the affluent neighborhoods of Los Angeles. The vast majority of Douglas Emmett's real estate portfolio is comprised of office buildings in Los Angeles. Most of these assets are located in the areas of Sherman Oaks, Woodland Hills, and Beverly Hills in terms of total square feet. Douglas Emmett derives nearly all of its income in the form of rental revenue from tenants. The vast majority of this also comes from its Los Angeles office buildings. The company's major tenants are legal, financial, and entertainment firms.

Stock Forecast FAQ

In the current month, DEI has received 2 Buy ratings 9 Hold ratings, and 0 Sell ratings. The DEI average analyst price target in the past 3 months is --.

  • Where Will Douglas Emmett Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Douglas Emmett share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Douglas Emmett?

    Analysts are divided on their view about Douglas Emmett share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Douglas Emmett is a Sell and believe this share price will rise from its current level to --.

  • What Is Douglas Emmett's Price Target?

    The price target for Douglas Emmett over the next 1-year time period is forecast to be -- according to 11 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 9 analysts rate the stock a Hold.

  • Is DEI A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Douglas Emmett is a Hold. 9 of 11 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of DEI?

    You can purchase shares of Douglas Emmett via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Douglas Emmett shares.

  • What Is The Douglas Emmett Share Price Today?

    Douglas Emmett was last trading at $19.00 per share. This represents the most recent stock quote for Douglas Emmett. Yesterday, Douglas Emmett closed at $18.99 per share.

  • How To Buy Douglas Emmett Stock Online?

    In order to purchase Douglas Emmett stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is up 49.85% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is up 49.62% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is up 10.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock